Ann Lab Med.  2012 May;32(3):210-215. 10.3343/alm.2012.32.3.210.

Prevalence of Hepatitis C Virus Infections and Distribution of Hepatitis C Virus Genotypes among Korean Blood Donors

• Oh DJ
• Park YM
• Seo YI
• Lee JS
• Lee JY

• KMID: 1381687
• DOI: http://doi.org/10.3343/alm.2012.32.3.210

Abstract

BACKGROUND
Hepatitis C virus (HCV) remains a worldwide health-care burden. Prevalence rates vary and the distribution of genotypes depends on geographical location. Here, the recent prevalence of HCV infections and distribution of HCV genotypes among Korean blood donors were studied.
METHODS
Between February 2005 and December 2009, a total of 11,064,532 donors were screened for anti-HCV and 11,412,690 donors were screened for HCV RNA. HCV genotyping was conducted for 748 blood donors with HCV RNA by using the line probe assay (VERSANT HCV Genotype 2.0 Assay, Bayer Healthcare, USA) after amplification of the 5'-untranslated and core regions of the genome.
RESULTS
The anti-HCV prevalence was 0.16% (17,250/11,064,532). HCV RNA was detected in 959 out of the 11,412,690 donors (8.4/100,000). HCV RNA was more prevalent among women, donors who resided at harbor sites, and first-time donors. In addition, the prevalence of HCV RNA increased with age. The genotypes of 740 out of the 748 tested donors (98.9%) were identified. HCV genotype 1b (47.7%) and 2a/2c (35.0%) were dominant. Genotypes 2 (7.6%), 2b (2.3%), 3a (1.6%), 1a (1.3%), 1 (0.9%), 2v (0.5%), 1v (0.1%), and 3 (0.1%) were also identified. Genotype 4a/4c/4d (0.1%) was detected for the first time in one Korean blood donor.
CONCLUSIONS
The distribution of HCV genotypes in Korea has not changed remarkably, with the exception of genotype 4a/4c/4d. A periodic study to monitor the prevalence of HCV infections and the distribution of HCV genotypes is required to identify emerging genotypes in Korea.

Keyword

Hepatitis C virus (HCV); Prevalence; Anti-HCV; HCV RNA; HCV genotype

MeSH Terms

5' Untranslated Regions
Adolescent
Adult
Aged
Blood Donors
Female
Genotype
Hepacivirus/*genetics/isolation & purification
Hepatitis C/*epidemiology/virology
Humans
Male
Middle Aged
RNA, Viral/analysis
Reagent Kits, Diagnostic
Republic of Korea/epidemiology
Young Adult

Reference

1. Sy T. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006. 3:41–46.

2. Lim YS. Current status of liver disease in Korea: Hepatitis C. Korean J Hepatol. 2009. 15(Suppl 6):S25–S28.

3. Shin HR. Epidemiology of Hepatitis C Virus in Korea. Intervirology. 2006. 49:18–22.

4. Jeong TH, Jeon TH. PCR prevalence and risk factors of hepatitis C virus infection in the adult population of Ulsan. J Korean Acad Fam Med. 1998. 19:364–373.

5. Seo WT, Lee SS. A study on positive rate of HBsAg, HBsAb and anti-HCV in Korean adults. Korean J Blood Transfus. 1998. 9:259–272.

6. Na HY, Park MH, Park KS, Sohn YH, Joo YE, Kim SJ. Geographic characteristics of positivity of anti-HCV and hepatitis B surface antigen in Kwangju and Chonnam Province: Survey data of 6,790 health screenees. Korean J Gastroenterol. 2001. 38:177–184.

7. Park KS, Lee YS, Lee SG, Hwang JY, Chung WJ, Cho KB, et al. A study on markers of viral hepatitis in adults living in Daegu and Gyungbuk area. Korean J Gastroenterol. 2003. 41:473–479.

8. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999. 341:556–562.

9. Simmonds P. Genetic diversity and evolution of hepatitis C virus -15 yr on. J Gen Virol. 2004. 85:3173–3188.

10. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005. 42:962–973.

11. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000. 13:223–235.

12. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994. 32:884–892.

13. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 1992. 188:331–341.

14. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci. 1994. 39:977–982.

15. Suh DJ, Jeong SH. Current status of hepatitis C virus infection in Korea. Intervirology. 2006. 49:70–75.

16. Kwon JH, Bae SH. Current status and clinical course of hepatitis C virus in Korea. Korean J Gastroenterol. 2008. 51:360–367.

17. Shin HR, Hwang SY, Nam CM. The prevalence of hepatitis C virus infection in Korea: pooled analysis. J Korean Med Sci. 2005. 20:985–988.

18. Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, et al. Distribution of hepatitis C virus genotypes in Jeju Island. Korean J Hepatol. 2008. 14:28–35.

19. Kim YS, Ahn YO, Lee HS. Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci. 2002. 17:187–192.

20. Han CJ, Lee HS, Kim HS, Choe JH, Kim CY. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Korean J Intern Med. 1997. 12:21–27.

21. Park YS, Lee KO, Oh MJ, Chai YG. Distribution of genotypes in the 5' untranslated region of hepatitis C virus in Korea. J Med Microbiol. 1998. 47:643–647.

22. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989. 244:359–362.

23. Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Lefrère JJ, et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol. 2007. 45:1140–1145.

24. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol. 2005. 75:538–549.

25. Lee GC, Kim HG, Park NH, Won SY, Chung YH, Lee YS, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection. Korean J Hepatol. 1998. 4:244–253.

26. Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, et al. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang. 2005. 88:10–16.

27. Simmonds P. Variability of hepatitis C virus. Hepatology. 1995. 21:570–583.